Marc Lustig

Marc Lustig

Directeur Général chez PHARMACIELO LTD.

Fortune : 2 M $ au 31/05/2026

53 ans
Finance
Process Industries
Health Technology

Profil

Marc Lustig was the founder of CannaRoyalty Corp., founded in 2015, serving as Executive Chairman & Chief Executive Officer from 2018 to 2020.
Mr. Lustig was the founder of Trichome Financial Corp., founded in 2017, serving as Chairman from 2017 to 2021.
Mr. Lustig is the founder of Cannabis Royalties & Holdings Corp., founded in 2015, serving as Chief Executive Officer & Director from 2015 to 2020.
Mr. Lustig is also the founder of Cedars Cancer Foundation.
Mr. Lustig is Chairman & Chief Executive Officer at PharmaCielo Ltd. since 2023.
Mr. Lustig is Director at Cresco Labs LLC.
Mr. Lustig is Independent Director at Aequus Pharmaceuticals, Inc. since 2021.
Mr. Lustig is Director at Resolve Digital Health, Inc. Mr. Lustig is Director at L5 Capital, Inc. Mr. Lustig is Director at Cresco Labs, Inc. (Arizona) since 2021.
Mr. Lustig is Director at Cresco Labs, Inc. since 2020.
Mr. Lustig was Chairman at META Growth Corp.
from 2018 to 2020.
Mr. Lustig was Chairman at Trichome Financial Corp.
Mr. Lustig was Chairman at Wellfield Technologies, Inc. from 2021 to 2023.
Mr. Lustig was Executive Chairman at IM Cannabis Corp.
from 2019 to 2024.
Mr. Lustig was Director at RF Capital Group, Inc. Mr. Lustig was Independent Director at 22 Capital Corp.
Mr. Lustig was Independent Director at Planet 13 Holdings, Inc. from 2018 to 2019.
Mr. Lustig was Independent Director at BriaCell Therapeutics Corp.
from 2021 to 2024.
Mr. Lustig was Head-Capital Markets at Merck & Co., Inc. Mr. Lustig was Principal at Griffiths McBurney Corp.
Mr. Lustig was Head-Capital Markets at Dundee Capital Markets, Inc. from 2012 to 2014.
Mr. Lustig was Sales Associate at GMP Securities LP.
Mr. Lustig was Vice President at Orion Securities, Inc. Mr. Lustig was Principal at KES 7 Capital, Inc. Mr. Lustig completed graduate and MBAistration degrees at McGill University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/03/2026 24 262 580 ( 12,91% ) 2 M $ 31/05/2026
23/02/2026 192 232 ( 0,06% ) 176 277 $ 31/05/2026
21/04/2025 10 198 958 ( 4,92% ) 71 393 $ 31/05/2026
10/12/2024 17 403 ( 0,24% ) 63 347 $ 31/05/2026
24/09/2025 6 916 666 ( 5,21% ) 6 917 $ 31/05/2026
01/08/2025 1 589 ( 99,94% ) 1 457 $ 31/05/2026

Postes actifs de Marc Lustig

SociétésPosteDébut
PHARMACIELO LTD. Directeur Général 10/07/2023
CRESCO LABS INC. Directeur/Membre du Conseil 29/07/2020
AEQUUS PHARMACEUTICALS INC. Directeur/Membre du Conseil 15/02/2021
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Marc Lustig

SociétésPosteFin
BRIACELL THERAPEUTICS CORP. Directeur/Membre du Conseil 23/11/2024
NAVASOTA RESOURCES INC Président 05/06/2024
WELLFIELD TECHNOLOGIES INC. Président 06/10/2023
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Marc Lustig

Formation de Marc Lustig

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

19

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Process Industries

Finance

Finance

Process Industries

Health Technology

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Process Industries

Finance

Process Industries

Process Industries

Cedars Cancer Foundation

Finance

Finance

Finance

  1. Bourse
  2. Insiders
  3. Marc Lustig
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT